-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$126.7548.21% Upside
Recent Analyst Forecasts and Stock Ratings
TransMedics Group, Inc. Frequently Asked Questions
-
What analysts cover TransMedics Group, Inc.?
TransMedics Group, Inc. has been rated by research analysts at Robert W. Baird, Canaccord Genuity, Needham, Oppenheimer, Piper Sandler, Morgan Stanley in the past 90 days.